1. 18TiPDESIGN OF A PHASE 2 STUDY OF BRENTUXIMAB VEDOTIN (SGN-35) AS SALVAGE THERAPY FOR MALES WITH CHEMORESISTANT GERM-CELL TUMORS (GCT). (November 2014) Authors: Giannatempo, P.; Anichini, A.; Raggi, D.; Cordareschi, E.; Nicolai, N.; Colecchia, M.; Salvioni, R.; Valagussa, P.; Gianni, A.; Necchi, A. Journal: Annals of oncology Issue: Volume 25(2014)Supplement 6 Page Start: vi6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Management of breast cancer after Hodgkin's lymphoma and paediatric cancer. Issue 13 (September 2015) Authors: Terenziani, M.; Massimino, M.; Magazzù, D.; Gandola, L.; Capri, G.; Carcangiu, M.L.; Catania, S.; Di Russo, A.; Gennaro, M.; Meazza, C.; Podda, M.; Schiavello, E.; Valagussa, P. Journal: European journal of cancer Issue: Volume 51:Issue 13(2015:Sep.) Page Start: 1667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoSphere study. (April 2018) Authors: Triulzi, T.; Di Cosimo, S.; Bianchini, G.; Pienkowski, T.; Im, Y.H.; Bianchi, G.V.; De Cecco, L.; Tseng, L.M.; Liu, M.C.; Lluch, A.; Semiglazov, V.; De la Haba-Rodriguez, J.; Oh, D.Y.; Poirier, B.; Pedrini, J.L.; Valagussa, P.; Tagliabue, E.; Gianni, L. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗